Manufacturing in Ireland has long helped many American drug companies pay lower taxes. But that strategy was designed for a ...

Due to a late change, the Spice Knowledge Sessions at Events Uncovered presented by Spice has a new opening keynote speaker ...

Eli Lilly ( NYSE: LLY) will raise the cost of its GLP-1/GIP receptor agonist Mounjaro (tirzepatide), approved for type 2 ...

Eli Lilly & Co. is raising the list price for its obesity shot in the UK by as much as 170%, as the pharma industry comes ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

The price hike is not expected to affect access for patients who receive Mounjaro through the National Health Service (NHS).

According to the Financial Times, the price for a month’s supply of the highest doses of the drug will rise from £122 to £330 ...

ADHD is characterized by difficulties with concentration and impulse control. Roughly 5% of children and 2.5% of adults are ...

Novo Nordisks stock has tumbled from record highs after slashing its 2025 outlook, as fierce competition, leadership changes, ...

From geopolitics to climate, tech to social change, News18 World live blog delivers real-time updates on what is the latest ...

SINGAPORE (Reuters) -Stocks in Asia made an uneven recovery as higher-than-expected producer price inflation dampened ...

Drugmakers Lilly and Novo have faced criticism about the cost of the treatments, which carry a list price of about $1,000 for a month's supply.